Viewing nowTraina Tablets 5 mg (Linagliptin Besilate)
Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 202400699 · Approved 2024.03.29 · Insurance code 694004230
Improvement of blood sugar control in type 2 diabetes
This medication is used to enhance blood sugar control in patients with type 2 diabetes, as an adjunct to diet and exercise. It is effective as monotherapy and can be expected to provide better blood sugar management when combined with other treatments.
The recommended dose of this medication is 5 mg of linagliptin once daily (6.67 mg of linagliptin besilate). It can be given without regard to meals. When used in combination with insulin or insulin secretagogues (such as sulfonylureas), lower doses of insulin and insulin secretagogues may be needed to minimize the risk of hypoglycemia.
This medication should not be used in patients with allergies to the active ingredient or any other components. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Caution is required as the risk of hypoglycemia may increase when used with medications that can cause hypoglycemia, such as insulin or sulfonylureas. Use is not recommended in patients with severe heart failure, and those with mild heart failure should use it cautiously. Symptoms of acute pancreatitis may occur; if continuous abdominal pain occurs, discontinue the medication immediately and consult a doctor. Dermatological adverse reactions such as bullous pemphigoid may occur; immediately inform healthcare providers if any skin abnormalities arise. Hypoglycemia may occur during treatment, so monitor symptoms and adjust dosage if necessary. Safety has not been established for use in pregnant or breastfeeding women; caution is advised, especially during breastfeeding. Safety and efficacy have not been sufficiently confirmed in pediatric or adolescent patients. There are no special dosage adjustments for the elderly, nor for patients with impaired kidney or liver function. In cases of overdose, it is important to take measures to prevent absorption in the gastrointestinal tract and receive appropriate treatment based on symptoms. Medications should be stored out of reach of children, and it is advisable to avoid transferring them to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and ensure safe use.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin Besylate 6.67mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.